Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL

NCT01358747 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Hodgkin's Lymphoma

Interventions

DRUG: BEACOPPesc
DRUG: BEACOPPesc - ABVD - PET2

Sponsor

Centre Hospitalier Universitaire Dijon

Collaborators

[object Object]